Actualités

The unsuspected role of PD-1 molecule in mycobacterial infections

13/07/2021

An innovative process to optimize blood stem cell transplantation

07/07/2021

Identification of a first genetic cause for tree-man syndrome (cutaneous papillomavirus)

01/07/2021

Discovery of a new gene responsible of syndromes causing aortic aneurysms

18/06/2021

AtmosR, Medetia and Institut Imagine launch collaboration to develop a treatment for Ondine syndrome

03/06/2021

COVID-19 and multisystemic inflammatory syndrome in children: 75% of affected children have the same immune abnormality

26/05/2021

Identification of a new genetic cause of intellectual disability

21/05/2021

An innovative method to characterize each cell individually

21/05/2021

Portrait - Marc Chevalier, Head of Bioentrepreneurship

06/05/2021

Discovery of a new genetic disease predisposing to mycobacterial infections

09/04/2021

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

09/04/2021

Institut Imagine accelerates research on autism spectrum disorders

25/03/2021

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

18/03/2021

Familial Hemophagocytic Lymphohystiocytosis and Digestive Malabsorption

17/03/2021

Research on nephronophthisis and renal ciliopathies at Imagine

16/03/2021